BGT
BIOGENETEC FPO [BGT]
Healthcare · ASX Small Cap
$0.0170 +0.0%
Updated 9 Sep 2026 · Signals refresh every scan
Appeared in 2 consecutive scansFirst seen: 2026-02-25
Get alerts when BGT triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- Stochastic is deep in oversold territory — bounce conditions forming
- Volume surging at 11.3x normal while price falls — heavy selling pressure
- Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
- Sitting near support — this level has held before and could attract buyers again
- Lagging the Small Ords index — relative strength of 0.79, underperforming its peers
- Adequate cash runway (4 quarters)
- Moderate P/S ratio (6.9x)
- Strong revenue growth (+106%)
- Near 52-week low (2% of range)
- Micro-cap ($5-20M) - high risk
- Sentiment is mixed — no strong consensus either way
- Revenue growing at +106% — the top line is moving in the right direction
- Altman Z-Score distress zone (1.40 < 1.81, low-confidence approx)
- Penny stock risk ($0.017)
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Deeply negative margins (-216%)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Long-term momentum is negative — down 21% over the past year
- The bigger volume days are the down days — volume-weighted momentum is negative (-1.70%/day)
Expected next for BGT
Window: 23 Oct to 6 Nov
The last 9 moved BGT +2.9% on the day, on average — an observation, not a guide to what happens next.
Each date is labelled with how it is known. A date estimated from past filings is inferred from this company's own filing rhythm — it is not a confirmed date and not a statement about what the company intends to do. See the whole ASX calendar →
Recent Catalysts
NONE Corporate Governance Statement
NONE Appendix 4G
NONE Change in substantial holding
LOW Appendix 4E and 2026 Annual Report
Recent ASX Announcements
| 2026-08-28 | Corporate Governance Statement |
| 2026-08-28 | Appendix 4G |
| 2026-08-28 | Appendix 4E and 2026 Annual Report PRICE SENSITIVE |
| 2026-08-27 | Change in substantial holding |
| 2026-08-27 | Change in substantial holding |
Key Metrics
$7.4M
Market Cap
252K
Avg Volume
11.3x
Vol Ratio
$0.02 — $0.06
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-125.4%
ROE
-216.0%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 55% |
| L | Leader vs Laggard | laggard | RS: -9 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
110 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track BGT and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required